Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $56,950 | 20 | 76.9% |
| Travel and Lodging | $8,683 | 14 | 11.7% |
| Food and Beverage | $5,886 | 78 | 7.9% |
| Honoraria | $2,077 | 3 | 2.8% |
| Entertainment | $454.36 | 7 | 0.6% |
| Debt forgiveness | $14.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $37,801 | 25 | $0 (2024) |
| Allergan, Inc. | $28,681 | 33 | $0 (2022) |
| Alimera Sciences, Inc. | $3,642 | 18 | $0 (2024) |
| Beaver-Visitec International, Inc. | $1,000 | 1 | $0 (2018) |
| Genentech USA, Inc. | $617.83 | 11 | $0 (2024) |
| OPTOS, INC. | $603.89 | 9 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $363.75 | 3 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $231.21 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $198.48 | 2 | $0 (2019) |
| Astellas Pharma US Inc | $148.91 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,435 | 15 | ABBVIE INC. ($14,873) |
| 2023 | $13,754 | 21 | AbbVie Inc. ($12,736) |
| 2022 | $13,324 | 21 | ABBVIE INC. ($10,192) |
| 2021 | $770.16 | 5 | Allergan, Inc. ($510.29) |
| 2020 | $10,900 | 17 | Allergan, Inc. ($8,793) |
| 2019 | $3,692 | 12 | Allergan Inc. ($3,035) |
| 2018 | $15,367 | 17 | Allergan Inc. ($14,123) |
| 2017 | $823.02 | 15 | Optos, Inc. ($454.36) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $91.28 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,950.00 | General |
| Category: EYE CARE | ||||||
| 09/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $1,567.46 | General |
| Category: EYE CARE | ||||||
| 09/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $119.13 | General |
| Category: EYE CARE | ||||||
| 08/29/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/22/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $161.00 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $36.77 | General |
| Category: EYE CARE | ||||||
| 07/12/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/21/2024 | ABBVIE INC. | OZURDEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,950.00 | General |
| Category: EYE CARE | ||||||
| 05/31/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/30/2024 | ABBVIE INC. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $1,128.75 | General |
| Category: EYE CARE | ||||||
| 05/30/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: EYE CARE | ||||||
| 05/08/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Ophthalmology | ||||||
| 04/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $128.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/17/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Food and Beverage | In-kind items and services | $94.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 12/19/2023 | AbbVie Inc. | OZURDEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,950.00 | General |
| Category: EYE CARE | ||||||
| 12/19/2023 | AbbVie Inc. | OZURDEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,250.00 | General |
| Category: EYE CARE | ||||||
| 12/12/2023 | AbbVie Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $1,591.20 | General |
| Category: EYE CARE | ||||||
| 12/12/2023 | AbbVie Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $531.80 | General |
| Category: EYE CARE | ||||||
| 12/12/2023 | AbbVie Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $237.48 | General |
| Category: EYE CARE | ||||||
| 12/12/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $85.62 | General |
| Category: EYE CARE | ||||||
| 12/12/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: EYE CARE | ||||||
| 12/12/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: EYE CARE | ||||||
| 12/12/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: EYE CARE | ||||||
| 11/14/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $94.00 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,659 | 28,411 | $4.8M | $2.4M |
| 2022 | 18 | 2,325 | 8,899 | $3.9M | $2.0M |
| 2021 | 22 | 2,833 | 11,713 | $4.3M | $2.3M |
| 2020 | 21 | 2,627 | 10,983 | $3.7M | $1.9M |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 158 | 1,816 | $2.3M | $1.2M | 55.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 63 | 19,740 | $1.1M | $570,082 | 52.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 41 | 830 | $380,380 | $150,126 | 39.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 303 | 1,635 | $475,200 | $145,106 | 30.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 682 | 1,151 | $198,568 | $100,643 | 50.7% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 31 | 371 | $97,634 | $58,669 | 60.1% |
| 92134 | Imaging of retina | Office | 2023 | 642 | 1,821 | $101,717 | $53,030 | 52.1% |
| J3590 | Unclassified biologics | Office | 2023 | 101 | 357 | $42,840 | $17,684 | 41.3% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2023 | 81 | 81 | $26,568 | $16,144 | 60.8% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 12 | 12 | $22,178 | $10,631 | 47.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 102 | 105 | $16,470 | $10,587 | 64.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 74 | 105 | $13,170 | $6,905 | 52.4% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 12 | 15 | $14,928 | $5,938 | 39.8% |
| 92250 | Photography of the retina | Office | 2023 | 120 | 123 | $10,428 | $3,106 | 29.8% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 16 | 17 | $11,730 | $3,099 | 26.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 28 | 28 | $6,058 | $2,633 | 43.5% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 145 | 145 | $3,748 | $1,610 | 43.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 17 | 28 | $2,520 | $1,535 | 60.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 31 | 31 | $1,114 | $583.75 | 52.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 134 | 1,748 | $2.2M | $1.2M | 56.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 48 | 1,439 | $665,742 | $314,640 | 47.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 251 | 1,566 | $442,750 | $140,552 | 31.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 611 | 1,097 | $183,199 | $93,618 | 51.1% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 37 | 371 | $99,109 | $58,346 | 58.9% |
| J3590 | Unclassified biologics | Office | 2022 | 94 | 418 | $107,400 | $53,137 | 49.5% |
About Dr. Ajay Singh, MD
Dr. Ajay Singh, MD is a Specialist healthcare provider based in Independence, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184807786.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajay Singh, MD has received a total of $74,065 in payments from pharmaceutical and medical device companies, with $15,435 received in 2024. These payments were reported across 123 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($56,950).
As a Medicare-enrolled provider, Singh has provided services to 10,444 Medicare beneficiaries, totaling 60,006 services with total Medicare billing of $8.7M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Retina Specialist, Ophthalmology
- Location Independence, MO
- Active Since 12/06/2007
- Last Updated 03/11/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184807786
Products in Payments
- OZURDEX (Drug) $66,482
- ILUVIEN (Drug) $3,232
- California (Device) $454.36
- EYLEA (Biological) $353.65
- Vabysmo (Drug) $240.10
- YUTIQ (Drug) $213.32
- VABYSMO (Drug) $166.72
- Iluvien (Drug) $153.93
- Monaco (Device) $149.53
- EYLEA HD (Biological) $128.28
- ForeseeHome (Device) $127.28
- Tecnis IOL (Medical Supply) $109.20
- Constellation (Device) $80.12
- Spectralis (Device) $79.88
- Cimerli (Biological) $27.36
- Susvimo (Drug) $24.46
- ACTHAR (Biological) $17.82
- STELLARIS PC (Device) $17.45
- Lucentis (Biological) $14.65
- DEXYCU (Drug) $14.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Independence
Dr. Timothy Hall, M.d, M.D
Specialist — Payments: $117,199
Dr. John Collins, M.d, M.D
Specialist — Payments: $793.47
Dr. Arthur Brock, Md, MD
Specialist — Payments: $34.91
Dr. Sol Dubin, M.d, M.D
Specialist — Payments: $33.72
Dr. Amy Trout, M.d, M.D
Specialist — Payments: $32.63
Dr. Burnell Landers, Md, MD
Specialist